Kenneth Lynard, EMBA
Chief Financial Officer
Nationality: Danish
Date of initial appointment: October 1, 2025
Mr. Lynard was appointed Chief Financial Officer (CFO) in 2025.
Mr. Lynard is a seasoned executive with over 20 years of global leadership experience in the life sciences industry, recognized for driving financial and operational transformation across complex, multinational organizations.
Before joining Pharming, Mr. Lynard served as CFO at Schoeller Allibert and Zentiva, a European pharmaceutical company. Previously, he served as CFO at Affidea, and notably worked for Gilead Sciences, a leading US-based biopharmaceutical company, as Senior Vice President and CFO, Global Commercial Operations, R&D and Manufacturing, guiding the company through a successful transformation as it expanded into broader therapeutic areas and new geographies. Earlier in his career, Mr. Lynard held finance leadership positions at Medtronic, Coloplast, Superfos and was a public accountant with Arthur Andersen.
Mr. Lynard holds a Master of Science in Business Economics and Auditing from Copenhagen Business School, Denmark, and an executive MBA from the International Institute for Management Development (IMD) in Lausanne, Switzerland.
ABOUT US | EXECUTIVE COMMITTEE | BOARD OF DIRECTORS | CORPORATE GOVERNANCE